Literature DB >> 3349328

Surgical morbidity and mortality in one hundred and twenty-nine patients with obstructive jaundice.

J D Greig1, Z H Krukowski, N A Matheson.   

Abstract

One hundred and twenty-nine jaundiced patients were operated upon for the relief of benign and malignant bile duct obstruction during a 10-year period, 1977-86. The overall mortality was 4.7 per cent but increased to 9.1 per cent in patients with a serum bilirubin greater than 300 mumol/l. In all, 46.5 per cent of patients had a rise in postoperative creatinine but renal dysfunction occurred in only 4.7 per cent. Wound infection developed in 3.1 per cent of patients and appeared unrelated to infected bile; 3.9 per cent of patients were treated for postoperative septicaemic episodes. The low morbidity and mortality observed suggests that preoperative biliary drainage need not be considered in routine surgical practice if simple measures to maintain urine flow and prevent postoperative sepsis are used.

Entities:  

Mesh:

Year:  1988        PMID: 3349328     DOI: 10.1002/bjs.1800750309

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  26 in total

1.  Effects of sulfasalazine on lipid peroxidation and histologic liver damage in a rat model of obstructive jaundice and obstructive jaundice with lipopolysaccharide-induced sepsis.

Authors:  Musa Dirlik; Aydin Karahan; Hakan Canbaz; Mehmet Caglikulekci; Ayşe Polat; Lulufer Tamer; Suha Aydin
Journal:  Curr Ther Res Clin Exp       Date:  2009-08

Review 2.  The current standard of care in the periprocedural management of the patient with obstructive jaundice.

Authors:  D L Clarke; Y Pillay; F Anderson; S R Thomson
Journal:  Ann R Coll Surg Engl       Date:  2006-11       Impact factor: 1.891

3.  The case against preoperative biliary drainage with pancreatic resection.

Authors:  Rurik C Johnson; Steven A Ahrendt
Journal:  HPB (Oxford)       Date:  2006       Impact factor: 3.647

Review 4.  Pathophysiology of increased intestinal permeability in obstructive jaundice.

Authors:  Stelios F Assimakopoulos; Chrisoula D Scopa; Constantine E Vagianos
Journal:  World J Gastroenterol       Date:  2007-12-28       Impact factor: 5.742

5.  Effect of preoperative biliary drainage on malignant obstructive jaundice: a meta-analysis.

Authors:  Yu-Dong Qiu; Jian-Ling Bai; Fang-Gui Xu; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2011-01-21       Impact factor: 5.742

6.  A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy.

Authors:  Katherine E Poruk; Joseph A Lin; Michol A Cooper; Jin He; Martin A Makary; Kenzo Hirose; John L Cameron; Timothy M Pawlik; Christopher L Wolfgang; Frederic Eckhauser; Matthew J Weiss
Journal:  HPB (Oxford)       Date:  2016-09-10       Impact factor: 3.647

7.  Impact of perioperative symbiotic therapy on infectious morbidity after Hpb Surgery in jaundiced patients: a randomized controlled trial.

Authors:  N Russolillo; A Ferrero; L Vigano'; S Langella; A Briozzo; M Ferlini; M Migliardi; L Capussotti
Journal:  Updates Surg       Date:  2014-08-07

8.  Effects of glycine on plasma and liver tissue changes of TNF-alpha, ET-1 and nitric oxide contents in rats with obstructive jaundice.

Authors:  He-Qing Fang; Ying-Bin Liu; Hai-Jun Li; Shu-You Peng; Yu-Lian Wu; Bin Xu; Jian-Wei Wang; Jiang-Tao Li; Xin-Bao Wang
Journal:  World J Gastroenterol       Date:  2003-10       Impact factor: 5.742

Review 9.  A meta-analysis on the efficacy of preoperative biliary drainage for tumors causing obstructive jaundice.

Authors:  Miguel E Sewnath; Thomas M Karsten; Martin H Prins; Erik J A Rauws; Huug Obertop; Dirk J Gouma
Journal:  Ann Surg       Date:  2002-07       Impact factor: 12.969

10.  Effects of n-3 Fatty Acids Supplementation on Plasma Phospholipids Fatty Acid Composition in Patients with Obstructive Jaundice- a Pilot Study.

Authors:  Tamara Popovic; Marija Ranic; Predrag Bulajic; Miroslav Milicevic; Aleksandra Arsic; Vesna Vucic; Marija Glibetic
Journal:  J Clin Biochem Nutr       Date:  2009-10-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.